These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression. Marek K; Jennings D; Tamagnan G; Seibyl J Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587 [TBL] [Abstract][Full Text] [Related]
4. Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease. Michell AW; Luheshi LM; Barker RA Neurosci Lett; 2005 Jun; 381(3):294-8. PubMed ID: 15896487 [TBL] [Abstract][Full Text] [Related]
5. Biomarkers in Huntington's and Parkinson's Disease. O'Keeffe GC; Michell AW; Barker RA Ann N Y Acad Sci; 2009 Oct; 1180():97-110. PubMed ID: 19906264 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers in Parkinson's disease: an update. Shtilbans A; Henchcliffe C Curr Opin Neurol; 2012 Aug; 25(4):460-5. PubMed ID: 22772875 [TBL] [Abstract][Full Text] [Related]
7. Early detection of Parkinson's disease: unmet needs. Gerlach M; Hendrich A; Hueber R; Jost W; Winkler J; Woitalla D; Riederer P Neurodegener Dis; 2008; 5(3-4):137-9. PubMed ID: 18322371 [TBL] [Abstract][Full Text] [Related]
8. The search for biomarkers in Parkinson's disease: a critical review. Antoniades CA; Barker RA Expert Rev Neurother; 2008 Dec; 8(12):1841-52. PubMed ID: 19086880 [TBL] [Abstract][Full Text] [Related]
9. Network biomarkers for the diagnosis and treatment of movement disorders. Poston KL; Eidelberg D Neurobiol Dis; 2009 Aug; 35(2):141-7. PubMed ID: 19013242 [TBL] [Abstract][Full Text] [Related]
11. Genomic and proteomic biomarkers for Parkinson disease. Gasser T Neurology; 2009 Feb; 72(7 Suppl):S27-31. PubMed ID: 19221311 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers for the early detection of Parkinson's and Alzheimer's disease. Berg D Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370 [TBL] [Abstract][Full Text] [Related]
13. Can we image premotor Parkinson disease? Marek K; Jennings D Neurology; 2009 Feb; 72(7 Suppl):S21-6. PubMed ID: 19221310 [TBL] [Abstract][Full Text] [Related]
14. Defining at-risk populations for Parkinson's disease: lessons from ongoing studies. Berg D; Marek K; Ross GW; Poewe W Mov Disord; 2012 Apr; 27(5):656-65. PubMed ID: 22508284 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers for the diagnosis and management of Parkinson's disease. Waragai M; Sekiyama K; Fujita M; Tokuda T; Hashimoto M Expert Opin Med Diagn; 2013 Jan; 7(1):71-83. PubMed ID: 23530844 [TBL] [Abstract][Full Text] [Related]
16. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Quinones MP; Kaddurah-Daouk R Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440 [TBL] [Abstract][Full Text] [Related]
17. Development of Parkinson's disease biomarkers. Prakash KM; Tan EK Expert Rev Neurother; 2010 Dec; 10(12):1811-25. PubMed ID: 21091313 [TBL] [Abstract][Full Text] [Related]
18. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. Goldknopf IL; Sheta EA; Bryson J; Folsom B; Wilson C; Duty J; Yen AA; Appel SH Biochem Biophys Res Commun; 2006 Apr; 342(4):1034-9. PubMed ID: 16516157 [TBL] [Abstract][Full Text] [Related]
19. [Cerebrospinal fluid biomarkers for the early diagnosis of Parkinson's disease]. da Costa AG; Gago MF; Garrett C Acta Med Port; 2011 Dec; 24 Suppl 4():761-8. PubMed ID: 22863482 [TBL] [Abstract][Full Text] [Related]